Director's Dealing • Jan 20, 2025
Director's Dealing
Open in ViewerOpens in native device viewer

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The issuer is solely responsible for the content of this announcement.
| a) Name | ||
|---|---|---|
| Title: | Dr. | |
| First name: | Karl | |
| Last name(s): | Mahler |
| Position: | Member of the administrative or supervisory body |
|---|---|
b) Initial notification
| a) Name | |||
|---|---|---|---|
| Marinomed Biotech AG | |||
| b) LEI |
529900GN3B1EN80XF405
| a) Description of the financial instrument, type of instrument, identification code | |||||
|---|---|---|---|---|---|
| Type: | Share | ||||
| ISIN: | ATMARINOMED6 | ||||
| b) Nature of the transaction | |||||
| Acquisition | |||||
| c) Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | ||||
| 14.00 EUR | 1,500 Units |
| d) Aggregated information | |
|---|---|
| Price | Aggregated volume |
| 14.00 EUR | 1,500 Units |
Outside a trading venue
| Language: Company: |
English Marinomed Biotech AG Hovengasse 25 2100 Korneuburg |
|---|---|
| Internet: | Austria www.marinomed.com |
End of News EQS News Service
96511 20.01.2025 CET/CEST
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.